SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
Sodium‐glucose co-transporter 2 (SGLT2) inhibitors have recently emerged as an effective means to protect kidney function in people with type 2 diabetes and chronic kidney disease (CKD). In this review, we explore the role of SGLT2 inhibition in these individuals. SGLT2 inhibitors specifically act t...
Saved in:
| Main Authors: | , , , , |
|---|---|
| 格式: | Revisão |
| 语言: | 英语 |
| 出版: |
2023
|
| 在线阅读: | https://doi.org/10.1530/ec-23-0005 https://ec.bioscientifica.com/downloadpdf/journals/ec/aop/ec-23-0005/ec-23-0005.pdf |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|